N/A
Completed N=35
Plasma Protein Binding Characteristics of Voriconazole
Focus of the Study:Protein Binding Characteristics of Voriconazole.
Source: ClinicalTrials.gov NCT01812473 ↗
Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcomePrimary: Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations. — 49.1; 49.6 % of plasma protein binding
Summary
The purpose of this study is to investigate the influence of hypoalbuminemia on the protein binding characteristics of the antifungal drug voriconazole in ICU patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations. |
49.1; 49.6 | — |
Eligibility Criteria
Inclusion Criteria
- treated with voriconazole
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT01812473). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.